Extensions for Using Data Elements from FHIR DSTU2 in FHIR R4B - Downloaded Version null See the Directory of published versions
| Page standards status: Trial-use | Maturity Level: 0 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="R2-v3-substanceAdminSubstitution-for-R4B"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet R2-v3-substanceAdminSubstitution-for-R4B</b></p><a name="R2-v3-substanceAdminSubstitution-for-R4B"> </a><a name="hcR2-v3-substanceAdminSubstitution-for-R4B"> </a><p>This value set expansion contains 10 concepts.</p><table class="codes"><tr><td><b>System</b></td><td><b>Version</b></td><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R4B-http://hl7.org/fhir/v3/substanceAdminSubstitution-BC"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-BC">BC</a></td><td>brand composition</td><td>Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R4B-http://hl7.org/fhir/v3/substanceAdminSubstitution-E"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-E">E</a></td><td>equivalent</td><td>Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R4B-http://hl7.org/fhir/v3/substanceAdminSubstitution-EC"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-EC">EC</a></td><td>equivalent composition</td><td>Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R4B-http://hl7.org/fhir/v3/substanceAdminSubstitution-F"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-F">F</a></td><td>formulary</td><td>Description: This substitution was performed or is permitted based on formulary guidelines.</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R4B-http://hl7.org/fhir/v3/substanceAdminSubstitution-G"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-G">G</a></td><td>generic composition</td><td>Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R4B-http://hl7.org/fhir/v3/substanceAdminSubstitution-N"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-N">N</a></td><td>none</td><td>No substitution occurred or is permitted.</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R4B-http://hl7.org/fhir/v3/substanceAdminSubstitution-TB"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-TB">TB</a></td><td>therapeutic brand</td><td>Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics > Examples: Zantac for Tagamet</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R4B-http://hl7.org/fhir/v3/substanceAdminSubstitution-TE"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-TE">TE</a></td><td>therapeutic alternative</td><td>Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R4B-http://hl7.org/fhir/v3/substanceAdminSubstitution-TG"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-TG">TG</a></td><td>therapeutic generic</td><td>Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands > Examples: Ranitidine for cimetidine</td></tr><tr><td><a name="R2-v3-substanceAdminSubstitution-for-R4B-http://hl7.org/fhir/v3/substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode"> </a><code>http://hl7.org/fhir/v3/substanceAdminSubstitution</code></td><td>1.0.2</td><td style="white-space:nowrap"> <a href="CodeSystem-v3-substanceAdminSubstitution.html#v3-substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode">_ActSubstanceAdminSubstitutionCode</a></td><td>ActSubstanceAdminSubstitutionCode</td><td>Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.</td></tr></table></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="fhir"/>
</extension>
<extension url="http://hl7.org/fhir/StructureDefinition/package-source">
<extension url="packageId">
<valueId value="hl7.fhir.uv.xver-r2.r4b"/>
</extension>
<extension url="version">
<valueString value="0.1.0"/>
</extension>
<extension url="uri">
<valueUri
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"/>
</extension>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
<valueInteger value="0">
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
<valueCanonical
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"/>
</extension>
</valueInteger>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
<valueCode value="trial-use">
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
<valueCanonical
value="http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"/>
</extension>
</valueCode>
</extension>
<url
value="http://hl7.org/fhir/uv/xver/ValueSet/R2-v3-substanceAdminSubstitution-for-R4B"/>
<version value="0.1.0"/>
<name value="R2V3SubstanceAdminSubstitutionForR4B"/>
<title
value="Cross-version ValueSet DSTU2.v3 Code System substanceAdminSubstitution for use in FHIR R4B"/>
<status value="active"/>
<experimental value="false"/>
<date value="2026-03-17T21:02:03.8104715+00:00"/>
<publisher value="FHIR Infrastructure"/>
<contact>
<name value="FHIR Infrastructure"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/fiwg"/>
</telecom>
</contact>
<description
value="This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31` for use in FHIR R4B."/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
<display value="World"/>
</coding>
</jurisdiction>
<purpose
value="This value set is part of the cross-version definitions generated to enable use of the
value set `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31` as defined in FHIR DSTU2
in FHIR R4B.
The source value set is bound to the following FHIR DSTU2 elements:
*
Across FHIR versions, the value set has been mapped as:
* `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31`
* `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2016-11-11`
* `http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution|2018-08-12`
Note that all concepts are included in this cross-version definition because no concepts have compatible representations
Following are the generation technical comments:
All concepts in the comparison are listed as identical.
The source and target value sets have the same number of active concepts (9).
All concepts in the comparison are listed as identical.
The source and target value sets have the same number of active concepts (9).
FHIR ValueSet `http://hl7.org/fhir/ValueSet/v3-substanceAdminSubstitution|2015-07-31`, defined in FHIR DSTU2 does not have any mapping to FHIR R4B"/>
<compose>
<include>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<concept>
<code value="BC"/>
<display value="brand composition"/>
</concept>
<concept>
<code value="E"/>
<display value="equivalent"/>
</concept>
<concept>
<code value="EC"/>
<display value="equivalent composition"/>
</concept>
<concept>
<code value="F"/>
<display value="formulary"/>
</concept>
<concept>
<code value="G"/>
<display value="generic composition"/>
</concept>
<concept>
<code value="N"/>
<display value="none"/>
</concept>
<concept>
<code value="TB"/>
<display value="therapeutic brand"/>
</concept>
<concept>
<code value="TE"/>
<display value="therapeutic alternative"/>
</concept>
<concept>
<code value="TG"/>
<display value="therapeutic generic"/>
</concept>
<concept>
<code value="_ActSubstanceAdminSubstitutionCode"/>
<display value="ActSubstanceAdminSubstitutionCode"/>
</concept>
</include>
</compose>
<expansion>
<timestamp value="2026-03-17T21:02:03.8104715+00:00"/>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="BC"/>
<display value="brand composition"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="E"/>
<display value="equivalent"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="EC"/>
<display value="equivalent composition"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="F"/>
<display value="formulary"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="G"/>
<display value="generic composition"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="N"/>
<display value="none"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="TB"/>
<display value="therapeutic brand"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="TE"/>
<display value="therapeutic alternative"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="TG"/>
<display value="therapeutic generic"/>
</contains>
<contains>
<system value="http://hl7.org/fhir/v3/substanceAdminSubstitution"/>
<version value="1.0.2"/>
<code value="_ActSubstanceAdminSubstitutionCode"/>
<display value="ActSubstanceAdminSubstitutionCode"/>
</contains>
</expansion>
</ValueSet>